To prohibit wholesalers from purchasing prescription drugs from pharmacies, and to enhance information and transparency regarding drug wholesalers engaged in interstate commerce.
The bill’s titles are written by its sponsor.
Sponsor and status
Sponsor. Representative for Maryland's 7th congressional district. Democrat.
Last Updated: May 22, 2012
Length: 11 pages
May 22, 2012
112th Congress, 2011–2013
Died in a previous Congress
This bill was introduced on May 22, 2012, in a previous session of Congress, but was not enacted.
May 22, 2012
May 14, 2013
Reintroduced Bill — Introduced
This activity took place on a related bill, H.R. 1958 (113th).
H.R. 5853 (112th) was a bill in the United States Congress.
A bill must be passed by both the House and Senate in identical form and then be signed by the President to become law.
This bill was introduced in the 112th Congress, which met from Jan 5, 2011 to Jan 3, 2013. Legislation not enacted by the end of a Congress is cleared from the books.
How to cite this information.
Civic Impulse. (2018). H.R. 5853 — 112th Congress: Gray Market Drug Reform and Transparency Act of 2012. Retrieved from https://www.govtrack.us/congress/bills/112/hr5853
“H.R. 5853 — 112th Congress: Gray Market Drug Reform and Transparency Act of 2012.” www.GovTrack.us. 2012. March 22, 2018 <https://www.govtrack.us/congress/bills/112/hr5853>
|title=H.R. 5853 (112th)
|accessdate=March 22, 2018
|author=112th Congress (2012)
|date=May 22, 2012
|quote=Gray Market Drug Reform and Transparency Act of 2012